EGenesis (Series A)

Funding Details
Awarder
Inbox
Date Award
March 25, 2017
Vertical
Life Sciences
Funding URL
View Funding Page
Funding Amount:
$38,000,000

Company Info
Founders
Luhan Yang
Company Description
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
Market
Human transplantable cells, tissues, and organs
Location
Cambridge, MA, USA
Coinvestors
Alexandria Real Estate Equities, Alta Partners, ARCH Venture Partners, Berggruen Holdings, Biomatics Capital, Fan Ventures, Heritage Provider Network, Uprising

Links